| Followers | 21 |
| Posts | 9812 |
| Boards Moderated | 0 |
| Alias Born | 11/04/2018 |
Thursday, April 04, 2024 4:40:23 PM
?????
Recent AVTX News
- Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/22/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 08:10:08 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 10:41:16 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 02:31:14 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/15/2026 12:15:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 11:02:12 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:00:44 AM
- Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates • GlobeNewswire Inc. • 05/13/2026 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2026 08:20:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2026 08:18:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2026 08:16:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2026 08:15:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 08:54:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 08:32:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 08:30:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 08:29:41 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/06/2026 03:00:55 PM
- Avalo Therapeutics Announces Pricing of $375 Million Public Offering • GlobeNewswire Inc. • 05/06/2026 03:33:54 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/05/2026 08:28:31 PM
- Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 05/05/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 08:01:30 PM
- Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa • GlobeNewswire Inc. • 05/05/2026 08:01:00 PM
